Stock Analiz

Neurogene Inc. (NGNE) stock forecast and price target

Price $23.93 · data as of November 13, 2026

12-month price target

Average target$77.62
Upside / downside+224.4%
Analysts8
ConsensusStrong buy
Low $46.00Average $77.62High $166.00

Gold marker: average target · white marker: today’s price ($23.93)

Analyst ratings

Strong buy 1Buy 9Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-5.00−18.0%$0
Next fiscal year
ends December 31, 2027
$-4.98+0.4%$0
Next quarter
ends December 31, 2026
$-1.12+1.1%$0
Quarter after
ends December 31, 2026
$-1.18−4.7%$0

Consensus of the analysts covering Neurogene, updated daily. In the last 30 days 1 estimates were raised and 3 lowered.

Frequently asked questions

What is the Neurogene stock price target?

The average 12-month target from 8 analysts is $77.62, 224.4% above the current price of $23.93 Targets range from $46.00 to $166.00.

Is Neurogene a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 9 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Neurogene expected to earn?

Analysts expect EPS of $-5.00 for the fiscal year ending December 31, 2026 and $-4.98 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.